Validity of the Danish National Registry of Patients for chemotherapy reporting among colorectal cancer patients is high
Open Access
- 1 August 2013
- journal article
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. 5, 327-34
Abstract
Peer reviewed article authored by (Lund JL, Frøslev T, Deleuran T, Erichsen R, Nilsson T, Pedersen AN, Høyer M). Read article or submit your manuscript for publishing.Keywords
This publication has 14 references indexed in Scilit:
- Identifying Specific Chemotherapeutic Agents in Medicare DataMedical Care, 2013
- Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patientsCancer, 2013
- Calendar time‐specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapyPharmacoepidemiology and Drug Safety, 2013
- Effect of Adjuvant Chemotherapy on Survival of Patients With Stage III Colon Cancer Diagnosed After Age 75 YearsJournal of Clinical Oncology, 2012
- Quality of ICD-10 colorectal cancer diagnosis codes in the Danish National Registry of PatientsEuropean Journal of Cancer Care, 2012
- Comparison of adverse events during 5‐fluorouracil versus 5‐fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancerCancer, 2012
- Completion of Therapy by Medicare Patients With Stage III Colon CancerJNCI: Journal of the National Cancer Institute, 2006
- Participation in Cancer Clinical TrialsJAMA, 2004
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Utility of the SEER-Medicare data to identify chemotherapy use.2002